FindTrial
Sign In

Transcutaneous Electrical Acupoint Stimulation for Treating Attention Deficit Hyperactivity Disorder: A Prospective, Randomized, Controlled Trial

Transcutaneous Electrical Acupoint Stimulation on Children with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004434
Enrollment
Unknown
Registered
2021-02-11
Start date
2019-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit/hyperactivity disorder (ADHD)

Interventions

TEAS group and Sham TEAS group:Transcutaneous Electrical Acupoint Stimulation

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Patients must be conform to ADHD clinical diagnostic criteria (DSM-V). Patients' ages are between 6~12 years old.

Exclusion criteria

Exclusion criteria: 1) combined with other mental and neurodevelopmental disorder (eg. autism spectrum disorder, tic disorder); 2) the IQ score of the participants below 75; 3) had the prior TEAS or other acupoints-associated treatment experiences; 4) left handedness.

Design outcomes

Primary

MeasureTime frame
The performance in Global Impression–Improvement scale;—

Countries

China

Contacts

Public ContactYan Li
liyanxjtu@xjtu.edu.cn13720418610

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026